Zobrazeno 1 - 10
of 1 420
pro vyhledávání: '"Pinnix CC"'
Autor:
Gunther JR; Department of Radiation Oncology, The University of TX MD Anderson Cancer Center, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, TX, USA., Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA., Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, TX, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, TX, USA., Clemens MW; Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, TX, USA., Pinnix CC; Department of Radiation Oncology, The University of TX MD Anderson Cancer Center, TX, USA.
Publikováno v:
Case reports in plastic surgery & hand surgery [Case Reports Plast Surg Hand Surg] 2024 Aug 07; Vol. 11 (1), pp. 2389172. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Autor:
Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Fang PQ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Wu SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Steiner R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Now with Department of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Neelapu S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston., Esmaeli B; Department of Ophthalmic Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Jul 11. Date of Electronic Publication: 2024 Jul 11.
Autor:
Wu SY; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Damron EP; The University of Texas Health Science Center at Houston, Houston, TX, USA., Xu J; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang PQ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai J; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malpica Castillo LE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fayad LE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Torres-Cabala CA; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vega F; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Miranda RN; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duvic M; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pinnix CC; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dabaja BS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huen AO; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gunther JR; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
International journal of dermatology [Int J Dermatol] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.
Autor:
Gunther JR; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Pinnix CC; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: ccpinnix@mdanderson.org.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Jul; Vol. 11 (7), pp. e472-e473.
Autor:
Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jgunther@mdanderson.org., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhutani MS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang PQ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhosale PR; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malpica Castillo L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parmer S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nze CC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Jul; Vol. 11 (7), pp. e521-e529. Date of Electronic Publication: 2024 Jun 03.
Autor:
LeCompte MC; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland. Electronic address: mlecomp2@jhmi.edu., Gibbs IC; Department of Radiation Oncology, Stanford University, Palo Alto, California., Taparra K; Department of Radiation Oncology, Stanford University, Palo Alto, California., Suneja G; Department of Radiation Oncology, University of Utah, Salt Lake City, Utah., Deville C Jr; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland., White Z 2nd; Department of Radiation Oncology, Stanford University, Palo Alto, California., MacDuffie E; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Pinnix CC; Department of Radiation Oncology, University of Texas MD Anderson Cancer, Houston, Texas., Kamrava M; Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, California., Jimenez RB; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Currey AD; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Chen Y; Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York., Franco I; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jun 27. Date of Electronic Publication: 2024 Jun 27.
Autor:
Fang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: pfang@mdanderson.org., Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Saini N; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Becnel MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kaufman G; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thomas SK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Amini B; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin P; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 May 01; Vol. 119 (1), pp. 193-199. Date of Electronic Publication: 2023 Dec 08.
Autor:
Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA
Publikováno v:
OncoTargets and Therapy, Vol Volume 11, Pp 8937-8942 (2018)
Ethan B Ludmir,1,* Tyler Gutschenritter,1,* Chelsea C Pinnix,1 Jillian R Gunther,1 Loretta J Nastoupil,2 Joseph D Khoury,3 L Jeffrey Medeiros,3 Bouthaina S Dabaja,1 Sarah A Milgrom1 1Department of Radiation Oncology, The University of Texas MD Anders
Externí odkaz:
https://doaj.org/article/975efa43abb94939b64f2304f0ae9846
Autor:
Wahid KA; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: kawahid@mdanderson.org., Rooney MK; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Gunther JR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Moreno AC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Pinnix CC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Thomas CR Jr; Radiation Oncology Department, Dartmouth Cancer Center & Geisel School of Medicine, Lebanon, New Hampshire., Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 01; Vol. 118 (3), pp. 590-594.
Autor:
Steiner RE; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Hwang SR; Division of Hematology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Khurana A; Division of Hematology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Habermann TM; Division of Hematology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Epperla N; The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH., Annunzio K; The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH., Allen PB; Winship Cancer Institute at Emory University, Atlanta, GA., Baird K; Winship Cancer Institute at Emory University, Atlanta, GA., Paulino D; Winship Cancer Institute at Emory University, Atlanta, GA., Alderuccio JP; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Lossos IS; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., David K; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pandya K; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Bair SM; University of Colorado Anschutz Medical Campus, Aurora, CO., Kamdar M; University of Colorado Anschutz Medical Campus, Aurora, CO., Ba Aqeel S; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Lynch R; University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA., Smith S; University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA., Feng L; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Noorani M; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Ahmed S; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Nair R; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX., Vega F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX., Wu S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Fang P; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Pinnix CC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Gunther JR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Dabaja BS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Lee HJ; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood advances [Blood Adv] 2023 Dec 26; Vol. 7 (24), pp. 7485-7493.